首页> 中文期刊> 《癌症》 >The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

         

摘要

Background:Elevated levels of serum C-reactive protein(CRP) have been reported to have prognostic significance in lung cancer patients.This study aimed to further identify CRP-bound components as prognostic markers for lung cancer and validate their prognostic value.Methods:CRP-bound components obtained from the serum samples from lung cancer patients or healthy controls were analyzed by differential proteomics analysis.CRP-bound serum amyloid A(CRP-SAA) was evaluated by coimmunoprecipitation(IP).Serum samples from two independent cohorts with lung cancer(retrospective cohort,242patients;prospective cohort,222 patients) and healthy controls(159 subjects) were used to evaluate the prognostic value of CRP-SAA by enzyme-linked immunosorbent assay.Results:CRP-SAA was identified specifically in serum samples from lung cancer patients by proteomic analysis.CRP binding to SAA was confirmed by co-IP in serum samples from lung cancer patients and cell culture media.The level of CRP-SAA was significantly higher in patients than in healthy controls(0.37 ± 0.58 vs.0.03 ± 0.04,P < 0.001).Elevated CRP-SAA levels were significantly associated with severe clinical features of lung cancer.The elevation of CRPSAA was associated with lower survival rates for both the retrospective(hazard ration[HR]= 2.181,95%confidence interval[CI]= 1.641-2.897,P < 0.001) and the prospective cohorts(HR = 2.744,95%CI = 1.810-4.161,P < 0.001).Multivariate Cox analysis showed that CRP-SAA was an independent prognostic marker for lung cancer.Remarkably,in stages l-ll patients,only CRP-SAA,not total SAA or CRP,showed significant association with overall survival in two cohorts.Moreover,univariate and multivariate Cox analyses also showed that only CRP-SAA could be used as an independent prognostic marker for early-stage lung cancer patients.Conclusion:CRP-SAA could be a better prognostic marker for lung cancer than total SAA or CRP,especially in earlystage patients.

著录项

  • 来源
    《癌症》 |2015年第8期|335-349|共15页
  • 作者单位

    State Key Laboratory of Oncology in South China;

    Collaborative Innovation Center for Cancer Medicine;

    Sun Yat-sen University Cancer Center;

    Department of Experimental Research;

    Sun Yat-sen University Cancer Center;

    Department of Pathogenic Biology;

    Guangzhou Hoffmann Institute of Immunology;

    School of Basic Sciences;

    Guangzhou Medical University;

    Department of Microbial and Biochemical Pharmacy;

    School of Pharmaceutical Sciences;

    Sun Yat-sen University;

    State Key Laboratory of Proteomics;

    Beijing Proteome Research Center;

    Beijing Institute of Radiation Medicine;

    Department of Clinical Laboratory;

    Sun Yat-sen University Cancer Center;

    Department of Gastrointestinal Surgery;

    Guangzhou Digestive Disease Center;

    Guangzhou First People's Hospital;

    Guangzhou Medical University;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 猪;蛋白质;
  • 关键词

    C反应蛋白; 血清样品; 肺癌; 预后; 价值; 早期; 结合物; 酶联免疫吸附试验;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号